<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03940040</url>
  </required_header>
  <id_info>
    <org_study_id>HFO_RCT</org_study_id>
    <nct_id>NCT03940040</nct_id>
  </id_info>
  <brief_title>High Flow Nasal Oxygen Versus Usual Care in COPD Pulmonary Rehabiliation</brief_title>
  <official_title>Comparing the Effect of High Flow Nasal Oxygen With Usual Care on Pulmonary Rehabilitation in COPD Patients After an Acute Exacerbation; a Pilot Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changi General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Changi General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the effects of high flow nasal oxygen with usual care during an outpatient 6-week
      pulmonary rehabilitation program after hospitalization for COPD exacerbation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a pilot randomized controlled trial to compare the effects of high flow nasal oxygen
      with usual care during an outpatient 6-week pulmonary rehabilitation program after
      hospitalization for COPD exacerbation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 28, 2019</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>6-minute walk distance</measure>
    <time_frame>6 weeks</time_frame>
    <description>It is the maximum distance walked in 6 minutes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>COPD Assessment Test score</measure>
    <time_frame>3 weeks, 6 weeks and 1 month after completion of program</time_frame>
    <description>Chronic obstructive pulmonary disease assessment test (CAT) score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety Depression Scale</measure>
    <time_frame>3 weeks, 6 weeks and 1 month after completion of program</time_frame>
    <description>This scale has 2 subscale scores of 1) Depression 2) Anxiety. Scores of 0-7 = Normal, 8-10 = Borderline, 11-21 = Abnormal</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory function test</measure>
    <time_frame>3 weeks, 6 weeks and 1 month after completion of program</time_frame>
    <description>It is a test of respiratory function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6-minute walk distance</measure>
    <time_frame>3 weeks and 1 month after completion of program</time_frame>
    <description>It is the maximum distance walked in 6 minutes</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">22</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will under go usual care ( pulmonary rehabilitation on room air or with nasal oxygen supplementation)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High flow nasal oxygen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will undergo pulmonary rehabilitation with high flow nasal oxygen</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual care</intervention_name>
    <description>Usual Care</description>
    <arm_group_label>Usual Care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High flow nasal oxygen</intervention_name>
    <description>High flow nasal oxygen</description>
    <arm_group_label>High flow nasal oxygen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 21 years and above

          2. Known diagnosis of COPD based on history AND spirometry demonstrating post
             bronchodilator FEV1/FVC ratio &lt;0.7

          3. Currently admitted inpatient for an acute COPD exacerbation as the primary diagnosis

          4. Fit to participate in exercise therapy as determined by both physician and
             physiotherapist

          5. Has the mental capacity to follow instructions

          6. Experience shortness of breath on exertion

          7. Have decreased ability to carry out activities due to shortness of breath

          8. Willing to participate in the exercise program

        Exclusion Criteria:

          1. Uncontrolled/ unstable medical conditions such as severe chronic heart failure that
             make exercise unsafe

          2. Pulmonary disorder other than COPD

          3. Physical conditions that preclude the ability to participate in exercise or may impair
             exercise performance.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yingjuan Mok, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Changi General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yingjuan Mok, MBS</last_name>
    <phone>68502600</phone>
    <email>mok.yingjuan@singhealth.com.sg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nur Shameerah Abdul Halim</last_name>
    <phone>68502600</phone>
    <email>Nur_Shameerah@cgh.com.sg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Changi General Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>529889</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yingjuan Mok, MBBS</last_name>
      <phone>68502600</phone>
      <email>mok.yingjuan@singhealth.com.sg</email>
    </contact>
    <contact_backup>
      <last_name>Nur Shameerah Abdul Halim</last_name>
      <phone>68502600</phone>
      <email>Nur_Shameerah@cgh.com.sg</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>May 5, 2019</study_first_submitted>
  <study_first_submitted_qc>May 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 7, 2019</study_first_posted>
  <last_update_submitted>September 1, 2019</last_update_submitted>
  <last_update_submitted_qc>September 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

